These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8212310)

  • 1. Modalities for reducing interleukin 1 activity in disease.
    Dinarello CA
    Trends Pharmacol Sci; 1993 May; 14(5):155-9. PubMed ID: 8212310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modalities for reducing interleukin 1 activity in disease.
    Dinarello CA
    Immunol Today; 1993 Jun; 14(6):260-4. PubMed ID: 8397767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 in disease.
    Dinarello CA
    Keio J Med; 1994 Sep; 43(3):131-6. PubMed ID: 7967307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin-1 in disease.
    Dinarello CA; Wolff SM
    N Engl J Med; 1993 Jan; 328(2):106-13. PubMed ID: 8439348
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of interleukin-1 in host responses to infectious diseases.
    Dinarello CA
    Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.
    Estrov Z; Kurzrock R; Talpaz M
    Leuk Lymphoma; 1993 Aug; 10(6):407-18. PubMed ID: 8401177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA; Thompson RC
    Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.
    Kurzrock R; Wetzler M; Estrov Z; Talpaz M
    Cytokines Mol Ther; 1995 Sep; 1(3):177-84. PubMed ID: 9384674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.
    Jotanovic Z; Mihelic R; Sestan B; Dembic Z
    Drugs Aging; 2012 May; 29(5):343-58. PubMed ID: 22550965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
    Estrov Z; Kurzrock R; Talpaz M
    Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
    Dinarello CA; Gelfand JA; Wolff SM
    JAMA; 1993 Apr; 269(14):1829-35. PubMed ID: 8459516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.
    Norman J; Franz M; Messina J; Riker A; Fabri PJ; Rosemurgy AS; Gower WR
    Surgery; 1995 Jun; 117(6):648-55. PubMed ID: 7539942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.
    Barton JL; Herbst R; Bosisio D; Higgins L; Nicklin MJ
    Eur J Immunol; 2000 Nov; 30(11):3299-308. PubMed ID: 11093146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process.
    Ando M; Kol S; Irahara M; Sirois J; Adashi EY
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):21-30. PubMed ID: 10619394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells.
    Viganò T; Habib A; Hernandez A; Bonazzi A; Boraschi D; Lebret M; Cassina E; Maclouf J; Sala A; Folco G
    Am J Respir Crit Care Med; 1997 Mar; 155(3):864-8. PubMed ID: 9117018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis.
    Moldawer LL
    Blood Purif; 1993; 11(2):128-33. PubMed ID: 8274244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages.
    Koch AE; Kunkel SL; Chensue SW; Haines GK; Strieter RM
    Clin Immunol Immunopathol; 1992 Oct; 65(1):23-9. PubMed ID: 1395121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
    Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
    J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of prostaglandin production in intact fetal membranes by interleukin-1 and its receptor antagonist.
    Brown NL; Alvi SA; Elder MG; Bennett PR; Sullivan MH
    J Endocrinol; 1998 Dec; 159(3):519-26. PubMed ID: 9834469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.